Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis
Journal of Dermatological Case Reports · 2008
DOI: 10.3315/jdcr.2008.1018 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Dermatological Case Reports, 2008. Verfasst von Uwe Wollina und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital of the Technical University of Dresden, Dresde…. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Abatacept is a soluble fusion protein approved as add-on drug in rheumatoid arthritis. MAIN OBSERVATIONS: Here we report the first case of fixed drug eruption followed by lichen aureus due to abatacept in a 67-year-old woman. CONCLUSION: Fixed drug eruption is an unexpected drug reaction for abatacept, since T-cell activation is inhibited.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology and Allergology, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital of the Technical University of Dresden, Dresden, Germany.
Zitieren
APA
Wollina, U., & Unger, L. (2008). Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis. Journal of Dermatological Case Reports. https://doi.org/10.3315/jdcr.2008.1018
Vancouver
Wollina U, Unger L. Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis. Journal of Dermatological Case Reports. 2008. doi:10.3315/jdcr.2008.1018
BibTeX
@article{Wollina2008,
author = {Wollina, Uwe and Unger, Leonore},
title = {Fixed drug eruption followed by lichen aureus during abatacept add-on therapy of rheumatoid arthritis},
journal = {Journal of Dermatological Case Reports},
year = {2008},
doi = {10.3315/jdcr.2008.1018}
}
EUVIMED